First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing
Authors
Keywords
-
Journal
ULTRASOUND IN OBSTETRICS & GYNECOLOGY
Volume 42, Issue 1, Pages 41-50
Publisher
Wiley
Online
2013-06-07
DOI
10.1002/uog.12511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross-trimester repeated measures testing for Down’s syndrome screening: an assessment
- (2014) D Wright et al. HEALTH TECHNOLOGY ASSESSMENT
- Maternal serum placental growth factor andα-fetoprotein testing in first trimester screening for Down syndrome
- (2013) Kim Donalson et al. PRENATAL DIAGNOSIS
- Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y
- (2013) K. H. Nicolaides et al. PRENATAL DIAGNOSIS
- A robust second-generation genome-wide test for fetal aneuploidy based on shotgun sequencing cell-free DNA in maternal blood
- (2013) N. Guex et al. PRENATAL DIAGNOSIS
- Maternal Serum Placental Growth Factor in Prospective Screening for Aneuploidies at 8–13 Weeks’ Gestation
- (2012) Pranav Pandya et al. FETAL DIAGNOSIS AND THERAPY
- A Mixture Model of Ductus Venosus Pulsatility Index in Screening for Aneuploidies at 11–13 Weeks’ Gestation
- (2012) Nerea Maiz et al. FETAL DIAGNOSIS AND THERAPY
- Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers
- (2012) Ranjit Akolekar et al. FETAL DIAGNOSIS AND THERAPY
- Combined Screening for Preeclampsia and Small for Gestational Age at 1113 Weeks
- (2012) Leona C.Y. Poon et al. FETAL DIAGNOSIS AND THERAPY
- Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing
- (2012) Tze Kin Lau et al. Journal of Maternal-Fetal & Neonatal Medicine
- Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing
- (2012) Diana W. Bianchi et al. OBSTETRICS AND GYNECOLOGY
- Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci
- (2012) Bernhard Zimmermann et al. PRENATAL DIAGNOSIS
- Impact of bias in crown-rump length measurement at first-trimester screening for trisomy 21
- (2012) K. O. Kagan et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting
- (2011) Mathias Ehrich et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood
- (2011) A. J. Sehnert et al. CLINICAL CHEMISTRY
- First-Trimester Screening for Trisomy 21 Using Alpha-Fetoprotein
- (2011) Foteini E. Bredaki et al. FETAL DIAGNOSIS AND THERAPY
- Maternal Serum α-Fetoprotein at 11–13 Weeks’ Gestation in Spontaneous Early Preterm Delivery
- (2011) Jarek Beta et al. FETAL DIAGNOSIS AND THERAPY
- DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study
- (2011) Glenn E. Palomaki et al. GENETICS IN MEDICINE
- Screening for fetal aneuploidies at 11 to 13 weeks
- (2011) Kypros H. Nicolaides PRENATAL DIAGNOSIS
- A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment
- (2011) Kypros H. Nicolaides PRENATAL DIAGNOSIS
- Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks
- (2011) Argyro Syngelaki et al. PRENATAL DIAGNOSIS
- Ductus Venosus in the First Trimester: Contribution to Screening of Chromosomal, Cardiac Defects and Monochorionic Twin Complications
- (2010) Nerea Maiz et al. FETAL DIAGNOSIS AND THERAPY
- First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation
- (2010) D. Wright et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free -hCG and pregnancy-associated plasma protein-A
- (2008) K. O. Kagan et al. HUMAN REPRODUCTION
- A mixture model of nuchal translucency thickness in screening for chromosomal defects
- (2008) D. Wright et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia
- (2008) R. Akolekar et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Learning curve for Doppler assessment of ductus venosus flow at 11 + 0 to 13 + 6 weeks' gestation
- (2008) N. Maiz et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started